The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are the challenges in assessing response to treatment in MDS?

Sep 29, 2020
Share:

During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the MDS Hub was happy to speak to Uwe Platzbecker, University of Leipzig Medical Center, Leipzig, DE. We asked: What are the challenges in assessing response to treatment in MDS?

What are the challenges in assessing response to treatment in MDS?

Treatment assessment in patients with low-risk MDS is particularly challenging. Here, Uwe Platzbecker highlights the need for uniform assessment approaches in MDS.

Share: